Solubilization and refolding of bacterial inclusion body proteins
- PMID: 16233795
- DOI: 10.1263/jbb.99.303
Solubilization and refolding of bacterial inclusion body proteins
Abstract
Inclusion bodies produced in Escherichia coli are composed of densely packed denatured protein molecules in the form of particles. Refolding of inclusion body proteins into bioactive forms is cumbersome, results in poor recovery and accounts for the major cost in production of recombinant proteins from E. coli. With new information available on the structure and function of protein aggregates in bacterial inclusion bodies, it has been possible to develop improved solubilization and refolding procedures for higher recovery of bioactive protein. Inclusion bodies are formed from partially folded protein intermediates and are composed of aggregates of mostly single types of polypeptide. This helps to isolate and purify the protein aggregates to homogeneity before solubilization and refolding. Proteins inside inclusion body aggregates have native-like secondary structures. It is assumed that restoration of this native-like secondary structure using mild solubilization conditions will help in improved recovery of bioactive protein in comparison to solubilization using a high concentration of chaotropic agent. Analysis of the dominant forces causing aggregation during inclusion body formation provides information to develop suitable mild solubilization procedures for inclusion body proteins. Refolding from such solubilized protein will be very high due to restoration of native-like secondary structure. Human growth hormone inclusion bodies were purified to homogeneity from E. coli cells before solubilization and refolding. Pure inclusion bodies were solubilized at alkaline pH in the presence of 2 M urea solution. The solubilized proteins were refolded using a pulsatile renaturation process and subsequently purified using chromatographic procedures. More than 40% of the inclusion body proteins could be refolded back to the bioactive native conformation. Mild solubilization is thus the key for high recovery of bioactive protein from inclusion bodies.
Similar articles
-
Recovery of bioactive protein from bacterial inclusion bodies using trifluoroethanol as solubilization agent.Microb Cell Fact. 2016 Jun 8;15:100. doi: 10.1186/s12934-016-0504-9. Microb Cell Fact. 2016. PMID: 27277580 Free PMC article.
-
Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli.Protein Expr Purif. 2000 Mar;18(2):182-92. doi: 10.1006/prep.1999.1179. Protein Expr Purif. 2000. PMID: 10686149
-
Solubilization of inclusion body proteins using n-propanol and its refolding into bioactive form.Protein Expr Purif. 2012 Jan;81(1):75-82. doi: 10.1016/j.pep.2011.09.004. Epub 2011 Sep 20. Protein Expr Purif. 2012. PMID: 21964443
-
Expression, Solubilization, Refolding and Final Purification of Recombinant Proteins as Expressed in the form of "Classical Inclusion Bodies" in E. coli.Protein Pept Lett. 2021;28(2):122-130. doi: 10.2174/0929866527999200729182831. Protein Pept Lett. 2021. PMID: 32729411 Review.
-
Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process.Microb Cell Fact. 2015 Mar 25;14:41. doi: 10.1186/s12934-015-0222-8. Microb Cell Fact. 2015. PMID: 25889252 Free PMC article. Review.
Cited by
-
Stabilizing additives added during cell lysis aid in the solubilization of recombinant proteins.PLoS One. 2012;7(12):e52482. doi: 10.1371/journal.pone.0052482. Epub 2012 Dec 20. PLoS One. 2012. PMID: 23285060 Free PMC article.
-
Aliivibrio wodanis as a production host: development of genetic tools for expression of cold-active enzymes.Microb Cell Fact. 2019 Nov 11;18(1):197. doi: 10.1186/s12934-019-1247-1. Microb Cell Fact. 2019. PMID: 31711487 Free PMC article.
-
Computational analysis of the amino acid interactions that promote or decrease protein solubility.Sci Rep. 2018 Oct 2;8(1):14661. doi: 10.1038/s41598-018-32988-w. Sci Rep. 2018. PMID: 30279585 Free PMC article.
-
Refolding of bioactive human epidermal growth factor from E. coli BL21(DE3) inclusion bodies & evaluations on its in vitro & in vivo bioactivity.Heliyon. 2022 Apr 18;8(4):e09306. doi: 10.1016/j.heliyon.2022.e09306. eCollection 2022 Apr. Heliyon. 2022. PMID: 35497033 Free PMC article.
-
Overexpression of an antimicrobial peptide derived from C. elegans using an aggregation-prone protein coexpression system.AMB Express. 2013 Aug 15;3(1):45. doi: 10.1186/2191-0855-3-45. AMB Express. 2013. PMID: 23945047 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources